Opus Genetics (IRD) Capital Expenditures (QoQ) (2010 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -52.95% |
| Sep 30, 2018 | 3,572.25% |
| Jun 30, 2018 | -61.39% |
| Mar 31, 2018 | -95.32% |
| Dec 31, 2017 | 1,455.33% |
| Sep 30, 2017 | -75.20% |
| Jun 30, 2017 | 251.70% |
| Mar 31, 2017 | 883.87% |
| Dec 31, 2016 | -46.41% |
| Sep 30, 2016 | -74.20% |
| Jun 30, 2016 | -36.58% |
| Mar 31, 2016 | -53.12% |
| Dec 31, 2015 | -75.56% |
| Sep 30, 2015 | 800.76% |
| Jun 30, 2015 | -43.88% |
| Mar 31, 2015 | -28.48% |
| Dec 31, 2014 | -30.40% |
| Sep 30, 2014 | 52.64% |
| Jun 30, 2014 | 176.93% |
| Mar 31, 2014 | 2.20% |
| Dec 31, 2013 | -91.77% |
| Sep 30, 2013 | 4,385.00% |
| Jun 30, 2013 | 64.20% |
| Dec 31, 2011 | 415.55% |
| Sep 30, 2011 | 4.78% |
| Dec 31, 2010 | 101.07% |